Skip to main content

Latest stock market podcasts

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Morning Bell 23 November

Paulina Peters
November 23, 2021

Morning Bell 22 November

Sophia Mavridis
November 22, 2021

Weekly Wrap 19 November

Sophia Mavridis
November 19, 2021

Morning Bell 18 November

Paulina Peters
November 18, 2021

Morning Bell 17 November

Sophia Mavridis
November 17, 2021

Morning Bell 16 November

Paulina Peters
November 16, 2021

Morning Bell 15 November

Sophia Mavridis
November 15, 2021

Weekly Wrap 12 November

Sophia Mavridis
November 12, 2021

Morning Bell 11 November

Paulina Peters
November 11, 2021

Morning Bell 10 November

Sophia Mavridis
November 10, 2021

Morning Bell 9 November

Paulina Peters
November 9, 2021

Morning Bell 8 November

Sophia Mavridis
November 8, 2021